John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 99,300 shares at $165.49 ($16.6M) on 2024-03-12, disclosed to the SEC on 2024-03-14.
Seasonal sale ($16.6M) by Chief Executive Officer — this insider has traded BGNE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $162.74 | 6,598 | $1.1M | 6.5% |
| 2 | $162.74 | 6,598 | $1.1M | 6.5% |
| 3 | $163.78 | 15,466 | $2.5M | 15.2% |
| 4 | $163.78 | 15,466 | $2.5M | 15.2% |
| 5 | $164.49 | 12,069 | $2.0M | 12.0% |
| 6 | $164.49 | 12,069 |
| $2.0M |
| 12.0% |
| 7 | $165.49 | 2,602 | $431K | 2.6% |
| 8 | $165.49 | 2,602 | $431K | 2.6% |
| 9 | $166.44 | 733 | $122K | 0.7% |
| 10 | $166.44 | 733 | $122K | 0.7% |
| 11 | $169.05 | 200 | $34K | 0.2% |
| 12 | $176.35 | 2,737 | $483K | 2.9% |
| 13 | $176.35 | 2,737 | $483K | 2.9% |
| 14 | $177.11 | 5,994 | $1.1M | 6.4% |
| 15 | $177.11 | 5,994 | $1.1M | 6.4% |
| 16 | $178.10 | 1,801 | $321K | 1.9% |
| 17 | $178.10 | 1,801 | $321K | 1.9% |
| 18 | $179.33 | 993 | $178K | 1.1% |
| 19 | $179.33 | 993 | $178K | 1.1% |
| 20 | $180.26 | 307 | $55K | 0.3% |
| 21 | $180.26 | 307 | $55K | 0.3% |
| 22 | $181.37 | 200 | $36K | 0.2% |
| 23 | $182.63 | 200 | $37K | 0.2% |
| 24 | $184.17 | 100 | $18K | 0.1% |
| Total | $167.28 avg | 99,300 | $16.6M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |